Industry Happenings -September 2026

FDA policy, shifting R&D priorities, and heightened oversight of overseas trials are shaping the future of drug development. Don’t miss the latest in BioPharma!

PDUFA Reauthorization Offers Chance for Clinical Trial Reforms. Will the US Take It?

FDA Building
Via Getty Images

Source: PharmaVoice

The upcoming reauthorization of the Prescription Drug User Fee Act (PDUFA) could create an opening for Congress to streamline U.S. clinical trials as competition from China’s research sector intensifies. While the FDA-industry fee agreement proposes a fee reduction for applications backed by U.S.-anchored Phase 1 trials, broader reforms would require congressional action. The effort also hinges on whether the FDA can rebuild and retain enough staff to meet its drug-review commitments.

READ FULL ARTICLE

Cancer Still Dominates Pharma R&D. Obesity is Gaining Ground.

Microscope
Via Getty Images

Source: PharmaVoice

Cancer remains the largest focus of pharmaceutical R&D, though its pipeline declined for a second consecutive year. At the same time, anti-obesity drug development surged 30.7% this year, and rare disease therapies now account for one-third of all pipeline drugs, underscoring a broader diversification of industry research.

READ FULL ARTICLE

Magnifying glass inspecting men in suits
Via Getty Images

FDA Raises Bar for Foreign Site Inspections as China Trials Surge

Source: BioSpace

The FDA plans to strengthen oversight of foreign clinical trial sites as China’s research activity continues to grow. The agency will expand inspections, work with sponsors earlier to assess data provenance and access, strengthen internal reviewer training, and scrutinize studies where data integrity or participant protections cannot be verified.

READ FULL ARTICLE

Need help navigating an ever-changing BioPharma landscape?

Recent Posts

Crowd of KOLs and DOLs

DOLs: A New Frontier

Whether you call them Key Opinion Leaders (KOLs) or Key External Experts (KEEs), success in the pharmaceutical space has always started with one essential task:...

Read More
Scientist in googles

Industry Happenings – October 2026

Learn how major industry trends are influencing the future of biopharma, including patent expiration challenges, evolving regulatory pathways, and emerging therapeutic targets that are attracting...

Read More
Magnifying glass inspecting men in suits

Industry Happenings -September 2026

FDA policy, shifting R&D priorities, and heightened oversight of overseas trials are shaping the future of drug development. Don’t miss the latest in BioPharma! Source:...

Read More